 | • レポートコード：D0804-00705 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗ウイルス剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗ウイルス剤の種類別市場規模（ジェネリック、ブランド）、用途別市場規模（HIV、肝炎、HSV、インフルエンザ）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Bristol-Myers-Squibb、GSK、Johnson & Johnson、F. Hoffmann-La Roche、Teva Pharmaceutical Industries、Aurobindo Pharma、Gilead Sciences、Mylan、AbbVie、Cipla、Dr Reddy’s ・地域別グローバル市場分析 2015年-2020年 ・抗ウイルス剤の北米市場（アメリカ、カナダ、メキシコ） ・抗ウイルス剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗ウイルス剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗ウイルス剤の南米市場（ブラジル、アルゼンチン） ・抗ウイルス剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ジェネリック、ブランド ・用途別分析：HIV、肝炎、HSV、インフルエンザ ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Antivirals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 53380 million by 2025, from USD 45100 million in 2019.
The Antivirals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Antivirals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Antivirals market has been segmented into
Generic
Branded
By Application, Antivirals has been segmented into:
HIV
Hepatitis
HSV
Influenza
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antivirals market presented in the report. This section sheds light on the sales growth of different regional and country-level Antivirals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antivirals market.
The report offers in-depth assessment of the growth and other aspects of the Antivirals market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Antivirals Market Share Analysis
Antivirals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antivirals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antivirals sales, revenue and market share for each player covered in this report.
The major players covered in Antivirals are:
Merck
Bristol-Myers-Squibb
GSK
Johnson & Johnson
F. Hoffmann-La Roche
Teva Pharmaceutical Industries
Aurobindo Pharma
Gilead Sciences
Mylan
AbbVie
Cipla
Dr Reddy’s
Among other players domestic and global, Antivirals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antivirals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antivirals, with price, sales, revenue and global market share of Antivirals in 2018 and 2019.
Chapter 3, the Antivirals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivirals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antivirals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antivirals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antivirals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antivirals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Generic
1.2.3 Branded
1.3 Market Analysis by Application
1.3.1 Overview: Global Antivirals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 HIV
1.3.3 Hepatitis
1.3.4 HSV
1.3.5 Influenza
1.4 Overview of Global Antivirals Market
1.4.1 Global Antivirals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers-Squibb
2.2.1 Bristol-Myers-Squibb Details
2.2.2 Bristol-Myers-Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers-Squibb SWOT Analysis
2.2.4 Bristol-Myers-Squibb Product and Services
2.2.5 Bristol-Myers-Squibb Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GSK SWOT Analysis
2.3.4 GSK Product and Services
2.3.5 GSK Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche SWOT Analysis
2.5.4 F. Hoffmann-La Roche Product and Services
2.5.5 F. Hoffmann-La Roche Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries
2.6.1 Teva Pharmaceutical Industries Details
2.6.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Product and Services
2.6.5 Teva Pharmaceutical Industries Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Aurobindo Pharma SWOT Analysis
2.7.4 Aurobindo Pharma Product and Services
2.7.5 Aurobindo Pharma Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Gilead Sciences
2.8.1 Gilead Sciences Details
2.8.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Gilead Sciences SWOT Analysis
2.8.4 Gilead Sciences Product and Services
2.8.5 Gilead Sciences Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mylan SWOT Analysis
2.9.4 Mylan Product and Services
2.9.5 Mylan Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AbbVie SWOT Analysis
2.10.4 AbbVie Product and Services
2.10.5 AbbVie Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cipla
2.11.1 Cipla Details
2.11.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cipla SWOT Analysis
2.11.4 Cipla Product and Services
2.11.5 Cipla Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Dr Reddy’s
2.12.1 Dr Reddy’s Details
2.12.2 Dr Reddy’s Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Dr Reddy’s SWOT Analysis
2.12.4 Dr Reddy’s Product and Services
2.12.5 Dr Reddy’s Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antivirals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antivirals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antivirals Manufacturer Market Share in 2019
3.3.2 Top 6 Antivirals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antivirals Sales, Revenue and Market Share by Regions
4.1.1 Global Antivirals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antivirals Revenue and Market Share by Regions (2015-2020)
4.2 North America Antivirals Sales and Growth Rate (2015-2020)
4.3 Europe Antivirals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antivirals Sales and Growth Rate (2015-2020)
4.5 South America Antivirals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antivirals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antivirals Sales, Revenue and Market Share by Country
5.1.1 North America Antivirals Sales and Market Share by Country (2015-2020)
5.1.2 North America Antivirals Revenue and Market Share by Country (2015-2020)
5.2 United States Antivirals Sales and Growth Rate (2015-2020)
5.3 Canada Antivirals Sales and Growth Rate (2015-2020)
5.4 Mexico Antivirals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antivirals Sales, Revenue and Market Share by Country
6.1.1 Europe Antivirals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antivirals Revenue and Market Share by Country (2015-2020)
6.2 Germany Antivirals Sales and Growth Rate (2015-2020)
6.3 UK Antivirals Sales and Growth Rate (2015-2020)
6.4 France Antivirals Sales and Growth Rate (2015-2020)
6.5 Russia Antivirals Sales and Growth Rate (2015-2020)
6.6 Italy Antivirals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antivirals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antivirals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antivirals Revenue and Market Share by Regions (2015-2020)
7.2 China Antivirals Sales and Growth Rate (2015-2020)
7.3 Japan Antivirals Sales and Growth Rate (2015-2020)
7.4 Korea Antivirals Sales and Growth Rate (2015-2020)
7.5 India Antivirals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antivirals Sales and Growth Rate (2015-2020)
7.7 Australia Antivirals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antivirals Sales, Revenue and Market Share by Country
8.1.1 South America Antivirals Sales and Market Share by Country (2015-2020)
8.1.2 South America Antivirals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antivirals Sales and Growth Rate (2015-2020)
8.3 Argentina Antivirals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antivirals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antivirals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antivirals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antivirals Sales and Growth Rate (2015-2020)
9.3 Turkey Antivirals Sales and Growth Rate (2015-2020)
9.4 Egypt Antivirals Sales and Growth Rate (2015-2020)
9.5 South Africa Antivirals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antivirals Sales and Market Share by Type (2015-2020)
10.2 Global Antivirals Revenue and Market Share by Type (2015-2020)
10.3 Global Antivirals Price by Type (2015-2020)
11 Global Antivirals Market Segment by Application
11.1 Global Antivirals Sales Market Share by Application (2015-2020)
11.2 Global Antivirals Revenue Market Share by Application (2015-2020)
11.3 Global Antivirals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antivirals Sales, Revenue and Growth Rate (2021-2025)
12.2 Antivirals Market Forecast by Regions (2021-2025)
12.2.1 North America Antivirals Market Forecast (2021-2025)
12.2.2 Europe Antivirals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antivirals Market Forecast (2021-2025)
12.2.4 South America Antivirals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antivirals Market Forecast (2021-2025)
12.3 Antivirals Market Forecast by Type (2021-2025)
12.3.1 Global Antivirals Sales Forecast by Type (2021-2025)
12.3.2 Global Antivirals Market Share Forecast by Type (2021-2025)
12.4 Antivirals Market Forecast by Application (2021-2025)
12.4.1 Global Antivirals Sales Forecast by Application (2021-2025)
12.4.2 Global Antivirals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Antivirals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antivirals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antivirals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Antivirals Major Business
Table 9. Merck Antivirals Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Antivirals Product and Services
Table 12. Merck Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers-Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers-Squibb Antivirals Major Business
Table 15. Bristol-Myers-Squibb Antivirals Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers-Squibb SWOT Analysis
Table 17. Bristol-Myers-Squibb Antivirals Product and Services
Table 18. Bristol-Myers-Squibb Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GSK Basic Information, Manufacturing Base and Competitors
Table 20. GSK Antivirals Major Business
Table 21. GSK Antivirals Total Revenue (USD Million) (2017-2018)
Table 22. GSK SWOT Analysis
Table 23. GSK Antivirals Product and Services
Table 24. GSK Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Antivirals Major Business
Table 27. Johnson & Johnson Antivirals Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Antivirals Product and Services
Table 30. Johnson & Johnson Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Antivirals Major Business
Table 33. F. Hoffmann-La Roche Antivirals Total Revenue (USD Million) (2017-2018)
Table 34. F. Hoffmann-La Roche SWOT Analysis
Table 35. F. Hoffmann-La Roche Antivirals Product and Services
Table 36. F. Hoffmann-La Roche Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pharmaceutical Industries Antivirals Major Business
Table 39. Teva Pharmaceutical Industries Antivirals Total Revenue (USD Million) (2017-2018)
Table 40. Teva Pharmaceutical Industries SWOT Analysis
Table 41. Teva Pharmaceutical Industries Antivirals Product and Services
Table 42. Teva Pharmaceutical Industries Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Aurobindo Pharma Antivirals Major Business
Table 45. Aurobindo Pharma Antivirals Total Revenue (USD Million) (2017-2018)
Table 46. Aurobindo Pharma SWOT Analysis
Table 47. Aurobindo Pharma Antivirals Product and Services
Table 48. Aurobindo Pharma Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 50. Gilead Sciences Antivirals Major Business
Table 51. Gilead Sciences Antivirals Total Revenue (USD Million) (2017-2018)
Table 52. Gilead Sciences SWOT Analysis
Table 53. Gilead Sciences Antivirals Product and Services
Table 54. Gilead Sciences Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Mylan Basic Information, Manufacturing Base and Competitors
Table 56. Mylan Antivirals Major Business
Table 57. Mylan Antivirals Total Revenue (USD Million) (2017-2018)
Table 58. Mylan SWOT Analysis
Table 59. Mylan Antivirals Product and Services
Table 60. Mylan Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Antivirals Major Business
Table 63. AbbVie Antivirals Total Revenue (USD Million) (2017-2018)
Table 64. AbbVie SWOT Analysis
Table 65. AbbVie Antivirals Product and Services
Table 66. AbbVie Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Cipla Basic Information, Manufacturing Base and Competitors
Table 68. Cipla Antivirals Major Business
Table 69. Cipla Antivirals Total Revenue (USD Million) (2017-2018)
Table 70. Cipla SWOT Analysis
Table 71. Cipla Antivirals Product and Services
Table 72. Cipla Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 74. Dr Reddy’s Antivirals Major Business
Table 75. Dr Reddy’s Antivirals Total Revenue (USD Million) (2017-2018)
Table 76. Dr Reddy’s SWOT Analysis
Table 77. Dr Reddy’s Antivirals Product and Services
Table 78. Dr Reddy’s Antivirals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Antivirals Sales by Manufacturer (2018-2019) (K MT)
Table 80. Global Antivirals Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Antivirals Sales by Regions (2015-2020) (K MT)
Table 82. Global Antivirals Sales Market Share by Regions (2015-2020)
Table 83. Global Antivirals Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Antivirals Sales by Countries (2015-2020) (K MT)
Table 85. North America Antivirals Sales Market Share by Countries (2015-2020)
Table 86. North America Antivirals Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Antivirals Revenue Market Share by Countries (2015-2020)
Table 88. Europe Antivirals Sales by Countries (2015-2020) (K MT)
Table 89. Europe Antivirals Sales Market Share by Countries (2015-2020)
Table 90. Europe Antivirals Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Antivirals Sales by Regions (2015-2020) (K MT)
Table 92. Asia-Pacific Antivirals Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Antivirals Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Antivirals Sales by Countries (2015-2020) (K MT)
Table 95. South America Antivirals Sales Market Share by Countries (2015-2020)
Table 96. South America Antivirals Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Antivirals Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Antivirals Sales by Countries (2015-2020) (K MT)
Table 99. Middle East & Africa Antivirals Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Antivirals Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Antivirals Revenue Market Share by Countries (2015-2020)
Table 102. Global Antivirals Sales by Type (2015-2020) (K MT)
Table 103. Global Antivirals Sales Share by Type (2015-2020)
Table 104. Global Antivirals Revenue by Type (2015-2020) (USD Million)
Table 105. Global Antivirals Revenue Share by Type (2015-2020)
Table 106. Global Antivirals Sales by Application (2015-2020) (K MT)
Table 107. Global Antivirals Sales Share by Application (2015-2020)
Table 108. Global Antivirals Sales Forecast by Regions (2021-2025) (K MT)
Table 109. Global Antivirals Market Share Forecast by Regions (2021-2025)
Table 110. Global Antivirals Sales Forecast by Type (2021-2025) (K MT)
Table 111. Global Antivirals Market Share Forecast by Type (2021-2025)
Table 112. Global Antivirals Sales Forecast by Application (2021-2025)
Table 113. Global Antivirals Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antivirals Picture
Figure 2. Global Sales Market Share of Antivirals by Type in 2019
Figure 3. Generic Picture
Figure 4. Branded Picture
Figure 5. Antivirals Sales Market Share by Application in 2018
Figure 6. HIV Picture
Figure 7. Hepatitis Picture
Figure 8. HSV Picture
Figure 9. Influenza Picture
Figure 10. Global Antivirals Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Antivirals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Antivirals Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Antivirals Sales Market Share by Manufacturer in 2019
Figure 31. Global Antivirals Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Antivirals Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Antivirals Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 36. Global Antivirals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Antivirals Revenue Market Share by Regions (2015-2020)
Figure 38. Global Antivirals Revenue Market Share by Regions in 2018
Figure 39. North America Antivirals Sales and Growth Rate (2015-2020)
Figure 40. Europe Antivirals Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antivirals Sales and Growth Rate (2015-2020)
Figure 42. South America Antivirals Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Antivirals Sales and Growth Rate (2015-2020)
Figure 44. North America Antivirals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Antivirals Sales Market Share by Countries (2015-2020)
Figure 46. North America Antivirals Sales Market Share by Countries in 2018
Figure 47. North America Antivirals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Antivirals Revenue Market Share by Countries in 2018
Figure 49. United States Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Canada Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Mexico Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Europe Antivirals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Antivirals Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Antivirals Revenue Market Share by Countries in 2019
Figure 55. Germany Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 56. UK Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 57. France Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Russia Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Italy Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Asia-Pacific Antivirals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Antivirals Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Antivirals Revenue Market Share by Regions 2019
Figure 63. China Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Japan Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Korea Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 66. India Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Southeast Asia Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 68. South America Antivirals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Antivirals Sales Market Share by Countries in 2019
Figure 70. South America Antivirals Revenue Market Share by Countries in 2019
Figure 71. Brazil Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Argentina Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Middle East and Africa Antivirals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Antivirals Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Antivirals Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Antivirals Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Egypt Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Turkey Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 80. South Africa Antivirals Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Global Antivirals Sales and Growth Rate (2021-2025) (K MT)
Figure 82. Global Antivirals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Antivirals Market Forecast (2021-2025) (K MT)
Figure 84. Europe Sales Antivirals Market Forecast (2021-2025) (K MT)
Figure 85. Asia-Pacific Sales Antivirals Market Forecast (2021-2025) (K MT)
Figure 86. South America Sales Antivirals Market Forecast (2021-2025) (K MT)
Figure 87. Middle East & Africa Sales Antivirals Market Forecast (2021-2025) (K MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
呼吸器系抗ウイルス薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Respiratory Antivirals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Respiratory Antivirals…- 角膜潰瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Corneal Ulcer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Corneal Ulcer Treatme…
- 抗インフルエンザ薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-influenza Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 従来式インフルエンザ診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Traditional influenza diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Traditional …
- 季節性インフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Seasonal Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 4404.4 million by 2025, from USD 4067.8 million in 2019. The Seasonal …